Literature DB >> 31303510

Phenotypical and functional analysis of donor lymphocyte infusion products after long-term cryopreservation.

Ann-Kathrin Schäfer1, Miguel Waterhouse2, Marie Follo3, Jesus Duque-Afonso1, Justus Duyster1, Hartmut Bertz1, Jürgen Finke1.   

Abstract

Donor lymphocyte infusions, collected from peripheral blood by apheresis, are regularly used to re-establishing disease control in patients with impending or full relapse after allogeneic cell transplantation. The cryopreservation and thawing processes of the cellular products, required for clinical needs, result in a decreased cellular recovery. The aim of this study was to perform an integral analysis of phenotypic and functional characteristics in different cell populations, within cryopreserved products used for therapeutic purposes. A total of 77 cryopreserved products were analysed. Cell viability and subpopulations such as CD3, CD4, CD8, CD14 and CD56 cells were quantified by FACS. Cell proliferation, cytotoxic capacity and CD4 intracellular ATP content were evaluated. A significant loss of cell viability was observed. CD56 cells were significantly reduced when compared with mononuclear cells without cryopreservation. Cell proliferation was also significantly reduced in the cryopreserved products. Cytotoxic capacity was decreased as well although it did not reach statistical significance. However, CD4 intracellular ATP was increased in the cryopreserved products. The analysed functional cell properties showed a wide distribution range although the apheresis, cryopreservation and thawing procedures were similar in all the analysed samples. Our findings may be useful for an improved characterisation of cryopreserved products to be used as donor lymphocyte infusion for therapeutic purposes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cryopreservation; Donor lymphocyte infusion; Functional analysis

Year:  2019        PMID: 31303510     DOI: 10.1016/j.transci.2019.06.022

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  4 in total

Review 1.  Cryopreservation as a Key Element in the Successful Delivery of Cell-Based Therapies-A Review.

Authors:  Julie Meneghel; Peter Kilbride; G John Morris
Journal:  Front Med (Lausanne)       Date:  2020-11-26

2.  Securing the graft during pandemic: are we ready for cryopreservation for all?

Authors:  Bhagirathbhai Dholaria; Monzr M Al Malki; Andrew Artz; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2020-04-17       Impact factor: 5.742

3.  Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.

Authors:  Andriyana K Bankova; Joseph Caveney; Bin Yao; Teresa L Ramos; Jan Bögeholz; Kartoosh Heydari; Nery Diaz; Marin L Jackson; Robert Lowsky; Janice Wes Brown; Laura Johnston; Andrew R Rezvani; Matthew J Frank; Lori Muffly; Wen-Kai Weng; Surbhi Sidana; Robert S Negrin; David B Miklos; Parveen Shiraz; Everett H Meyer; Judith A Shizuru; Sally Arai
Journal:  Transplant Cell Ther       Date:  2022-01-15

4.  Transplantation of allogeneic cryopreserved hematopoietic cell grafts during the Covid-19 pandemic: A National Marrow Donor Program perspective.

Authors:  Steven M Devine
Journal:  Am J Hematol       Date:  2020-12-02       Impact factor: 13.265

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.